相关实验视频
Updated: Sep 11, 2025
06:40
Seven Steps to Stellate Cells
Published on: May 10, 2011
34.1K
探索肝星细胞驱动纤维化:治疗进展和未来的前景
Alka Singh1, Ansab Akhtar2, Prashant Shukla1
1Department of Pharmaceutical Sciences, School of Health Sciences and Technology, UPES, Dehradun, India.
ADMET & DMPK
|August 11, 2025
概括
肝纤维化治疗由于复杂的原因而面临挑战. 本综述探讨了肝星细胞 (HSC) 的新目标和有效治疗肝纤维化的先进策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 纤维化研究 纤维化研究
- 药物开发 药物开发
背景情况:
- 肝纤维化是一种进展性疾病,具有重大全球健康影响.
- 病毒和代谢原因导致肝纤维化,可能导致肝硬化和癌症.
- 目前治疗肝纤维化的疗法取得的成功有限,很少有FDA批准的药物.
研究的目的:
- 审查肝纤维化的病理生理学,专注于新的治疗点.
- 检查肝纤维化的当前和新兴治疗策略,包括药理学药物和活性向.
- 确定研究缺口,并指导未来肝纤维化治疗中的临床转化.
主要方法:
- 对肝纤维化病理生理特征的审查.
- 对肝星细胞 (HSC) 中新型点的分析.
- 检查临床前和临床治疗策略.
- 探索活性药物输送向策略的探索.
- 整合关于新型途径的知识 (RSPO3-LGR4/5-β-catenin,CD47/YAP/TEAD4,HAb18G/CD147) 的知识.
- 包括单细胞RNA测序数据用于HSCs.
主要成果:
- 在肝星细胞 (HSC) 中确定纤维化的主要点.
- 评估各种治疗方法,包括药理学药物和积极向策略.
- 开发涉及HSC激活和潜在治疗干预点的新信号通路.
- 突出显示单细胞RNA测序洞察力,了解肝纤维化中的HSC异质性.
结论:
- 在肝纤维化治疗方面存在关键的研究缺口.
- 有希望的积极向策略和药理干预措施可以改善治疗结果.
- 这一审查为开发更安全,更有效的肝纤维化药物配方提供了基础.
相关概念视频
01:24Liver Regeneration
3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
201
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
201